FIRST AID ANTISPETIC- benzalkonium chloride spray

First Aid Antispetic by

Drug Labeling and Warnings

First Aid Antispetic by is a Otc medication manufactured, distributed, or labeled by Orazen Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient

Benzalkonium chloride 0.13%

Purpose

First aid antiseptic

Uses

first aid to help prevent infection in minor cuts, scrapes and burns

Warnings

For external use only

Do not use

• in the eyes or apply over large areas of the body
• longer than 1 week unless directed by a doctor
  

Ask a doctor before use if you have

• deep or puncture wounds, animal bites, or serious burns

Stop use and ask a doctor if

• the condition persists or gets worse

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• clean the affected area
• spray a small amount of this product on the area 1 to 3 times daily
• may be covered with a sterile bandage
• if bandaged, let dry first

Other information

• store at room temperature
• you may report a serious adverse reaction to this product to 1-866-651-3660

Inactive ingredients

ethyl alcohol, purified water

Questions?

1-866-651-3660
Mon-Fri 8:00am-5:00pm EST

Package Label - Principal Display Panel

INGREDIENTS AND APPEARANCE

FIRST AID ANTISPETIC 
benzalkonium chloride spray

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 71927-011
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y)	BENZALKONIUM CHLORIDE	0.13 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
ALCOHOL (UNII: 3K9958V90M)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 71927-011-01	59.1 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product	10/03/2022

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M003	10/03/2022

Labeler - Orazen Inc (080916640)